• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

LY2109761

(CAS: 700874-71-1)

Suppliers of LY2109761

Company Name Email Tel Country
Active Biopharma Corp [email protected] +86 (571) 8161-2335 China

Fax: Purity: Brand:

Apexbio Technology LLC [email protected] +1-832-696-8203 USA

Fax: +1-832-641-3177Purity: 98% Brand: Tocris

CHEMSCENE, LLC [email protected] 732-484-9848 USA

Fax: 888-484-5008Purity: >98% Brand:

Price and Availability: USD180/5mg (In stock) USD288/10mg (In stock) USD810/50mg (In stock)

MedChemexpress Co., Ltd. [email protected] 609-228-6898 USA

Fax: 609-228-5909Purity: >98% Brand:

Price and Availability: USD180/5mg (In stock) USD288/10mg (In stock) USD810/50mg (In stock)
Quality Control & MSDS Files: HNMR HNMR LCMS LCMS MSDS

Selleck Chemicals LLC [email protected] +1-832-582-8158 USA

Fax: +1-832-582-8590Purity: >98% Brand:

Price and Availability: USD270/5mg (In stock) USD370/10mg (In stock) USD432/10mM/1mLIn DMSO (In stock) USD1070/50mg (In stock) USD2470/200mg (In stock)
Quality Control & MSDS Files: HPLC

Shanghai Haoyuan Chemexpress Co., Ltd. [email protected] +86 (21) 5187-0955 / +86 (21) 5895-5995 China

Fax: +86 (21) 5895-5996Purity: >98% Brand:

Price and Availability: USD180/5mg (In stock) USD288/10mg (In stock) USD810/50mg (In stock)

Target Molecule Corp. [email protected] (857) 239-0968 USA

Fax: 857-239-8801Purity: .98 Brand: TargetMol

Price and Availability: USD174/10mg () USD348/25mg () USD648/50mg ()

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:
Remarks:
 

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of LY2109761

LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively; shown to negatively affect the phosphorylation of Smad2. IC50 value: 38 nM/300 nM(Ki, TβRI/II) [1] Target: TGF-β receptor type I/II in vitro: LY2109761 treatment induces a dose-dependent low-anchorage growth inhibition of L3.6pl/GLT cells, leading to ~33% or 73% inhibition at 2 μM and 20 μM, respectively, which can be strongly enhanced when combined with gemcitabine in combination index value of 0.36581.

Solubility of LY2109761

Solubility Sources
Limited solubility Apexbio Technology LLC
DMSO MedChemexpress Co., Ltd.
DMSO <1 mg/mL (<1 mM) ; Water <1 mg/mL (<1 mM) ; Ethanol <1 mg/mL (<1 mM) Selleck Chemicals LLC

Storage Condition of LY2109761

Storage Condition Sources
Store at -20&deg;C Apexbio Technology LLC

MSDS Information

MSDS Sources
MedChemexpress Co., Ltd.

Quality Control and Spectral Data

QC Reports Sources
[HNMR] [LCMS] MedChemexpress Co., Ltd.
[HPLC] Selleck Chemicals LLC

Mechanism and Indications

Signaling Pathways TGF-beta/Smad Autophagy
Target Autophagy TGF-β Receptor
Research Area Cancer
Indications Glioblastoma Hepatocellular carcinoma Glioma

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
LY2109761 Eli Lilly & Co Glioblastoma 2012/4/30 2014/8/31 Phase 2 Clinical
LY2109761 Eli Lilly & Co Hepatocellular carcinoma 2011/3/31 2015/5/31 Phase 2 Clinical
LY2109761 Eli Lilly & Co Glioma 2011/4/30 2015/1/31 Phase 2 Clinical
LY2109761 Eli Lilly & Co 2013/10/31 2013/11/30 Phase 1 Clinical
LY2109761 Eli Lilly & Co 2013/1/31 2013/2/28 Phase 1 Clinical
LY2109761 - No Development Reported

Chemical Information

M.Wt Formula CAS No. Synonyms
441.52 C26H27N5O2 700874-71-1 LY 2109761;LY-2109761; 4-(2-((4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine

Structure Information of LY2109761

Smiles N12N=C(C(C3=C4C=CC(OCCN5CCOCC5)=CC4=NC=C3)=C1CCC2)C6=NC=CC=C6
InChI InChI=1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2

Related Products

Other Form Products of LY2109761

Name CAS Formula Suppliers

Recommended Products in Same Target

Name CAS Formula Suppliers
Pirarubicin (Hydrochloride) 95343-20-7 C32H38ClNO12 4
Berberine (chloride hydrate) 141433-60-5 C20H18ClNO4 6
DMH-1 1206711-16-1 C24H20N4O 16
CB-839 1439399-58-2 C26H24F3N7O3S 8
H 89 (hydrochloride) 130964-39-5 C20H22BrCl2N3O2S 8
Shikonin 517-89-5 C16H16O5 14
H 89 127243-85-0 C20H20BrN3O2S 5
Eupatilin 22368-21-4 C18H16O7 7
Isoalantolactone 470-17-7 C15H20O2 6
Scutellarein 529-53-3 C15H10O6 9
Leonurine 24697-74-3 C14H21N3O5 4
Berbamine (hydrochloride) 6078-17-7 C37H42Cl2N2O6 17
Ruxolitinib (S enantiomer) 941685-37-6 C17H18N6 10
D-Glucosamine (Hydrochloride) 66-84-2 C6H14ClNO5 26
Schizandrin A 61281-38-7 C22H28O6 6
Schisandrol B 58546-54-6 C23H28O7 4
Schisandrol A 7432-28-2 C24H32O7 6
Anhydroicaritin 118525-40-9 C21H20O6 3
Bicyclol 118159-48-1 C19H18O9 4
Azithromycin (hydrate) 117772-70-0 C38H72N2O12 16

Recommended Products in the Same Indication

Name CAS Formula Suppliers
BMS-599626 (Hydrochloride) 873837-23-1 C27H28ClFN8O3 4
Tivantinib 905854-02-6 C23H19N3O2 8
Nordihydroguaiaretic acid 500-38-9 C18H22O4 8
Brivanib (alaninate) 649735-63-7 C22H24FN5O4 7
Resminostat 864814-88-0 C16H19N3O4S 11
Sorafenib (Tosylate) 475207-59-1 C28H24ClF3N4O6S 14
Lenvatinib 417716-92-8 C21H19ClN4O4 5
Temozolomide 85622-93-1 C6H6N6O2 26
Cabozantinib 849217-68-1 C28H24FN3O5 16
Mefloquine (hydrochloride) 51773-92-3 C17H17ClF6N2O 14
Crenolanib 670220-88-9 C26H29N5O2 6
LY2157299 700874-72-2 C22H19N5O 9
VAL-083 23261-20-3 C6H10O4 8
Tirapazamine 27314-97-2 C7H6N4O2 10
Ispinesib 336113-53-2 C30H33ClN4O2 17
BMS-599626 714971-09-2 C27H27FN8O3 6
Bosutinib 380843-75-4 C26H29Cl2N5O3 11
Cilengitide 188968-51-6 C27H40N8O7 8
Sorafenib 284461-73-0 C21H16ClF3N4O3 15
Cediranib 288383-20-0 C25H27FN4O3 8

Chemical and Physical Properties

Appearance:White to off-white solid Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:
Optical Rotation: alpha:

Tags: buy LY2109761 | LY2109761 IC50 | LY2109761 price | LY2109761 cost | LY2109761 solubility | LY2109761 purchase | LY2109761 manufacturer | LY2109761 research buy | LY2109761 order | LY2109761 MSDS | LY2109761 chemical structure | LY2109761 Storage condition | LY2109761 molecular weight | LY2109761 mw | LY2109761 datasheet | LY2109761 supplier | LY2109761 cell line | LY2109761 NMR | LY2109761 MS | LY2109761 IR | LY2109761 solubility | LY2109761 Safe information | LY2109761 Qc and Spectral Information | LY2109761 Clinical Information | LY2109761 Clinical Trial | LY2109761 Route of Synthesis | LY2109761 storage condition | LY2109761 diseases and conditions | LY2109761 flash point | LY2109761 boiling point | LY2109761 melting point | LY2109761 storage condition | LY2109761 brand